within Pharmacolibrary.Drugs.R_RespiratorySystem.R01A_DecongestantsAndOtherNasalPreparationsForTopicalUse.R01AX30_XylometazolineAndDexamethasone;
model XylometazolineAndDexamethasone 
   extends Pharmacolibrary.Drugs.ATC.R.R01AX30;

  annotation(Documentation(
    info ="<html><body><p>The combination of xylometazoline, a topical nasal decongestant (alpha-adrenergic agonist), and dexamethasone, a corticosteroid with anti-inflammatory properties, is used in intranasal preparations to reduce nasal congestion and inflammation associated with rhinitis or sinusitis. It is not widely approved as a fixed drug combination in major markets, but is referenced under ATC code R01AX30.</p><h4>Pharmacokinetics</h4><p>No direct pharmacokinetic (PK) studies on the combination product exist. Estimates are based on published data of each substance administered intranasally in healthy adults.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end XylometazolineAndDexamethasone;
